Status:
UNKNOWN
The Prostate Liquid Study (PLiS)
Lead Sponsor:
University College, London
Conditions:
Prostate Cancer
Eligibility:
MALE
40+ years
Brief Summary
A multi-site study to evaluate the potential use of the ChEC test of seminal fluid as an additional triage test in stratifying patients for further tests.
Detailed Description
A biomarker is a molecular substance that is an indicator of a biological condition. Cambridge Oncometrix believe that a semen biomarker may be able to predict the presence of prostate cancer. This st...
Eligibility Criteria
Inclusion
- \- Men over 40 years old with suspected prostate cancer who have been referred to a secondary care
- \- Men able to produce a semen sample
- \- Men able to have a prostate mpMRI
- \- Men who have given their written informed consent
Exclusion
- \- Previous history of prostate biopsy
- \- Contraindication to MRI
- \- Previous history of prostate surgery
- \- Treatment with 5-alpha-reductase inhibitors at time of registration or during the prior 6 months
- \- Evidence of urinary tract infection or history of acute prostatitis within the last month
- \- Androgen replacement therapy within the last 3 months
- \- Any other medical condition precluding standard diagnostic workup and collection of semen samples.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04102904
Start Date
October 1 2019
End Date
March 1 2021
Last Update
March 26 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University College Hospital
London, United Kingdom
2
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norwich, United Kingdom